Mycobacterium tuberculosis Next-Generation Whole Genome Sequencing: Opportunities and Challenges

الملخص EN

Mycobacterium tuberculosis drug resistance is a threat to global tuberculosis (TB) control.

Comprehensive and timely drug susceptibility determination is critical to inform appropriate treatment of drug-resistant tuberculosis (DR-TB).

Phenotypic drug susceptibility testing (DST) is the gold standard for M.

tuberculosis drug resistance determination.

M.

tuberculosis whole genome sequencing (WGS) has the potential to be a one-stop method for both comprehensive DST and epidemiological investigations.

We discuss in this review the tremendous opportunities that next-generation WGS presents in terms of understanding the molecular epidemiology of tuberculosis and mechanisms of drug resistance.

The potential clinical value and public health impact in the areas of DST for patient management and tracing of transmission chains for timely public health intervention are also discussed.

We present the current challenges for the implementation of WGS in low and middle-income settings.

WGS analysis has already been adapted routinely in laboratories to inform patient management and public health interventions in low burden high-income settings such as the United Kingdom.

We predict that the technology will be adapted similarly in high burden settings where the impact on the epidemic will be greatest.